title: Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms.
abstract: The myeloproliferative neoplasms are a heterogeneous group of clonal disorders characterized by the overproduction of mature cells in the peripheral blood, together with an increased risk of thrombosis and progression to acute myeloid leukemia. The majority of patients with Philadelphia-chromosome negative myeloproliferative neoplasms harbor somatic mutations in Janus kinase 2, leading to constitutive activation. Acquired mutations in calreticulin or myeloproliferative leukemia virus oncogene are found in a significant number of patients with essential thrombocythemia or myelofibrosis, and mutations in numerous epigenetic regulators and spliceosome components are also seen. Although the cellular and molecular consequences of many of these mutations remain unclear, it seems likely that they interact with germline and microenvironmental factors to influence disease pathogenesis. This review will focus on the determinants of specific myeloproliferative neoplasm phenotypes as well as on how an improved understanding of molecular mechanisms can inform our understanding of the disease entities themselves.
authors.affiliation: Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.|Department of Haematology, Addenbrooke's Hospital, Cambridge, UK.
authors.forename: Jacob
authors.initials: J
authors.lastname: Grinfeld
authors.affiliation: Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.|Department of Haematology, Addenbrooke's Hospital, Cambridge, UK.
authors.forename: Jyoti
authors.initials: J
authors.lastname: Nangalia
authors.affiliation: Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK arg1000@cam.ac.uk.|Department of Haematology, Addenbrooke's Hospital, Cambridge, UK.
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Green
mesh_terms: D000818:Animals; D015415:Biomarkers; D004198:Disease Susceptibility; D004777:Environment; D005786:Gene Expression Regulation; D006801:Humans; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000209:etiology* / Q000378:metabolism; D010641:Phenotype; D018121:Receptors, Cytokine / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D015415:Biomarkers; D018121:Receptors, Cytokine